Automated identification of circulating tumor cells by image cytometry (Q34101560)

31 July 2017

title

Automated identification of circulating tumor cells by image cytometry (English)

1 reference

31 July 2017

0 references

6

Leon W M M Terstappen

1 reference

31 July 2017

Tycho M Scholtens

1

1 reference

31 July 2017

Frederik Schreuder

2

1 reference

31 July 2017

Sjoerd T Ligthart

3

1 reference

31 July 2017

Joost F Swennenhuis

4

1 reference

31 July 2017

Jan Greve

5

1 reference

31 July 2017

publication date

13 December 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

81

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

138-148

1 reference

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

A rare-cell detector for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

High speed detection of circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Detection and characterization of carcinoma cells in the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Apoptosis of circulating tumor cells in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

CellTracks TDI: an image cytometer for cell characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Magnetic field design for selecting and aligning immunomagnetic labeled cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Sensitivity measurement and compensation in spectral imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Automatic tracking, feature extraction and classification of C elegans phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Apoptosis generates stable fragments of human type I keratins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Identification and characterization of circulating prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Circulating breast cancer cells are frequently apoptotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

A novel high-through-put assay for screening of pro-apoptotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Keratin 8/18 breakdown and reorganization during apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Isolation of rare cells from cell mixtures by dielectrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

The random subspace method for constructing decision forests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Measuring nominal scale agreement among many raters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Statistical considerations for enumeration of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

7 January 2021

Random Forests for land cover classification

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

7 January 2021

The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

7 January 2021

Characterization of circulating tumor cells by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

7 January 2021

An immunohistochemical study of the clearance of apoptotic cellular fragments

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

7 January 2021

CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22002

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.22002

1 reference

31 July 2017

1 reference